知镜 Cognispect · 医学文献与研究工作台

Clinical Outcome and Prognostic Factors in Childhood Acute Lymphoblastic Leukemia-A Retrospective Cohort Study of Patients from Southern Mexico.

Morales-Vital F, Moreno-Loaeza D, Alvarado-Castro VM, Meza-Miranda J, López-Camarillo C, Escoto-Hernández R, Ojeda-Campos LA, Garibay-Cerdenares OL, Ocampo-Bárcenas A, Ibarra-Sierra E.
Journal of clinical medicine · 2026-08-31 · PMID 42739763

文献摘要

Background/Objectives : B-cell acute lymphoblastic leukemia (B-ALL) remains the most common pediatric malignancy. This study aimed to evaluate clinical outcomes in pediatric B-ALL in Southern Mexico and determine how socioeconomic vulnerabilities-specifically indigenous status and treatment non-adherence-independently drive relapse and compromise survival in a resource-limited setting. Methods : A retrospective cohort study was conducted, including 146 patients (0-17 years) treated between 2010 and 2024 using modified Total XIII and XV protocols. Survival was estimated via Kaplan-Meier. Independent prognostic factors for overall survival (OS) and relapse were identified using multivariable Cox proportional hazards models. Results : The 5-year OS was 50%, and event-free survival (EFS) was 37.6%. Survival varied significantly by clinical risk: 88% for low-risk, 77% for standard-risk, and 31% for high-risk patients. Relapse occurred in 45.8% of patients. Beyond established biological predictors like hyperleukocytosis and high-risk cytogenetics, socioeconomic vulnerabilities profoundly impacted outcomes. Documented treatment non-adherence significantly reduced 5-year OS (23.4% vs. 56.1%, p = 0.001) and disproportionately affected indigenous patients (55.5% vs. 10.1% in non-indigenous). Multivariable analysis identified indigenous status as an independent predictor of increased relapse hazard (HR = 1.89, p = 0.049), alongside male sex and high leukocyte count. Conclusions : Survival outcomes in this cohort are markedly lower than in high-income countries. The high incidence of relapse is deeply intertwined with local structural inequities. Improving survival requires complementing biological risk stratification with targeted strategies to overcome socioeconomic barriers and prevent treatment non-adherence.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。